Clinical Trial Update: Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of lapatinib for brain metastases in ErbB2-positive breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Neoplasms, Breast | Phase 2 | Status: COMPLETED | Results posted: 2019-12-12